Daewoong Pharmaceutical Co. Ltd.

This study tests the drug apremilast in 425 adults with moderate-to-severe psoriasis that has lasted at least 6 months. The main goal is to see how many people achieve at least a 75% improvement in skin symptoms after 16 weeks. The study is open-label, meaning everyone knows they…

This study will observe 12,000 Korean adults with high cholesterol who are prescribed Baroezet Tablet by their doctor. Researchers will track changes in cholesterol levels and any side effects over 24 weeks. The goal is to see how well the medication works in everyday medical pra…

This study looks at whether a daily tablet called Fexuclue 20 mg can prevent stomach ulcers in people who need to take NSAID pain relievers long-term. About 7,000 adults in Korea will take the medicine and report any stomach symptoms over 4 weeks. The goal is to see if the drug r…

This study tests two nasal devices (Noseguard and Noseguard Night) to see if they can lower the chance of getting respiratory infections like COVID-19 and the flu. About 2,000 adults will use the devices for 8 weeks, and researchers will track infection rates and how easy the dev…

This study tests whether a new medicine called Fexuprazan can prevent stomach ulcers in people who need to take NSAID pain relievers (like ibuprofen) for at least 24 weeks. About 360 adults with joint or muscle pain will receive either Fexuprazan or an older ulcer-prevention drug…

This early-stage study tests a new drug called DWRX5003 in 72 healthy adults to see if it is safe and how the body processes it compared to similar drugs. Participants must be between 19 and 65 years old with a healthy weight. The study does not aim to treat any disease, but to g…